COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,693 Articles (22,913 medRxiv, 8,780 bioRxiv)

Most recent first Previous |  Page 2349: Articles 23481-23490  | Next

Do Lockdowns Bring about Additional Mortality Benefits or Costs? Evidence based on Death Records from 300 Million Chinese People
Qi, J., Zhang, D., Zhang, X., Yin, P., Liu, J., Pan, Y., Takana, T., Xie, P., Wang, Z., Liu, S., Gao, G. F., He, G., Zhou, M.
10.1101/2020.08.28.20183699 — Posted: 2020-09-01
On Statistical Power for Case-Control Host Genomic Studies of COVID-19
Lin, Y.-C., Brooks, J. D., Bull, S. B., Gagnon, F., Greenwood, C. M., Hung, R. J., Lawless, J., Paterson, A., Sun, L., Strug, L. J.
10.1101/2020.08.26.20182840 — Posted: 2020-09-01
Systematic review and meta-analysis identifies potential host therapeutic targets in COVID-19.
Parkinson, N., Rodgers, N., Head Fourman, M., Wang, B., Zechner, M., Swets, M., Millar, J. E., Law, A., Russell, C., Baillie, J. K., Clohisey, S.
10.1101/2020.08.27.20182238 — Posted: 2020-09-01
County-level exposures to greenness and associations with COVID-19 incidence and mortality in the United States
Klompmaker, J. O., Hart, J. E., Holland, I., Sabath, M. B., Wu, X., Laden, F., Dominici, F., James, P.
10.1101/2020.08.26.20181644 — Posted: 2020-09-01 Discussion: Onsite
Post-COVID-19 Functional Status: Relation to age, smoking, hospitalization and comorbidities
Mohamed-Hussein, A., Galal, I., Saad, M., Zayan, H. E., Abdelsayed, M., Moustafa, M., Ezzat, A. R., Helmy, R., Abd Elaal, H., Aly, K., Abderheem, S.
10.1101/2020.08.26.20182618 — Posted: 2020-09-01
A multipurpose machine learning approach to predict COVID-19 negative prognosis in Sao Paulo, Brazil
Fernandes, F. T., Oliveira, T. A. d., Teixeira, C. E., Batista, A. F. d. M., Costa, G. D., Chiavegatto Filho, A.
10.1101/2020.08.26.20182584 — Posted: 2020-09-01
Risk factors for SARS-CoV-2 infection, hospitalisation, and death in Catalonia, Spain: a population-based cross-sectional study
Villar-Garcia, J., Vivanco-Hidalgo, R. M., Cleries, M., Martinez, E., Monterde, D., Perez-Sust, P., Garcia-Eroles, L., Sais, C., Moharra, M., Vela, E.
10.1101/2020.08.26.20182303 — Posted: 2020-09-01
Ethnic disparities in COVID-19 mortality in Mexico: a cross-sectional study based on national data
Ibarra-Nava, I., Flores-Rodriguez, K. G., Ruiz-Herrera, V., Ochoa-Bayona, H. C., Salinas-Zertuche, A., Padilla-Orozco, M., Salazar-Montalvo, R. G.
10.1101/2020.08.26.20182543 — Posted: 2020-09-01
Beyond Six Feet: A Guideline to Limit Indoor Airborne Transmission of COVID-19
Bazant, M. Z., Bush, J. W. M.
10.1101/2020.08.26.20182824 — Posted: 2020-09-01 Discussion: Onsite
Joint Investigation of Two-Month Post-Diagnosis IgG Antibody Levels and Psychological Measures for Assessing Longer Term Multi-Faceted Recovery among COVID-19 Cases in Northern Cyprus
Barin, B., Yoldascan, B. E., Savaskan, F., Ozbalikci, G., Karaderi, T., Cakal, H.
10.1101/2020.08.27.20178160 — Posted: 2020-09-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).